No black box warning on record for Etoposide

As of the latest FDA labeling reviewed, Etoposide (ETOPOSIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Etoposide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Patients being treated with etoposide Injection USP must be frequently observed for myelosuppression both during and after therapy. Myelosuppression resulting in death has been reported. Dose-limiting bone marrow suppression is the most significant toxicity associated with etoposide Injection USP therapy. Therefore, the following studies should be obtained at the start of therapy and prio

No black box warning on record for Etoposide

Other warnings & precautions

WARNINGS Patients being treated with etoposide Injection USP must be frequently observed for myelosuppression both during and after therapy. Myelosuppression resulting in death has been reported. Dose-limiting bone marrow suppression is the most significant toxicity associated with etoposide Injection USP therapy. Therefore, the following studies should be obtained at the start of therapy and prio

Etoposide Black Box Warning

No black box warning on record for Etoposide

Other warnings & precautions

Etoposide Black Box Warning

No black box warning on record for Etoposide

Other warnings & precautions